Laurus Labs Q3 Results
- BSE: 540222
- NSE: LAURUSLABS
- ISIN: INE947Q01028
- Sector: Biotechnology & Drugs
BSE
984.45
33.85 (3.56%)
33.85 (3.56%)Volume1.74 L
Updated: Mon 9 Feb, 2026 | 15:25:48
NSE
985.5034.95 (3.68%)
34.95 (3.68%)Volume1.49 M
Updated: Mon 9 Feb, 2026 | 15:44:22
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹1,778.29 Cr.(25.67%)
- Operating Profit₹359.59 Cr.(100.82%)
- Profit After Tax₹251.66 Cr.(172.65%)
- Operating Margin20.22%(59.80%)
Note: Comparison is on YoY basis
Quarterly - Laurus Labs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,418.70 | 1,152.88 | 3.50% | 1,235.99 | 14.78% |
| Depreciation/ Amortization | 120.62 | 107.51 | 0.11% | 106.09 | 13.70% |
| Operating Income | 359.59 | 70.82 | 27.17% | 179.06 | 100.82% |
| Net Income | 251.66 | 19.84 | 29.08% | 92.30 | 172.65% |
| Other Operating Expenses Total | 374.27 | 318.35 | 0.82% | 330.63 | 13.20% |
| Net Income Before Taxes | 326.56 | 22.81 | 21.07% | 130.68 | 149.89% |
| Total Revenue | 1,778.29 | 1,223.70 | 7.55% | 1,415.05 | 25.67% |
| Selling/ General/ Admin Expenses Total | 229.24 | 178.72 | 6.35% | 189.12 | 21.21% |
| Diluted Normalized EPS | 4.65 | 0.37 | 28.81% | 1.71 | 171.93% |